ArticleCancer discovery2013

GSK-3α promotes oncogenic KRAS function in pancreatic cancer via TAK1-TAB stabilization and regulation of noncanonical NF-κB.

Deepali Bang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.